The Mainz Severity Score Index (MSSI): development and validation of a system for scoring the signs and symptoms of Fabry disease

被引：42

作者：

Beck, M ^{[1
]}

机构：

[1] Univ Mainz, Childrens Hosp, D-6500 Mainz, Germany

来源：

ACTA PAEDIATRICA | 2006年 / 95卷

关键词：

Fabry disease; MSSI;

D O I：

10.1080/08035320600618825

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Fabry disease is a rare lysosomal storage disorder caused by the deficient activity of the lysosomal enzyme a-galactosidase A. The resultant storage of undegraded glycolipids leads to the progressive development of potentially life-threatening manifestations affecting multiple organ systems in the body. This paper describes the development of the Mainz Severity Score Index (MSSI), a scoring system for patients with Fabry disease. Conclusion: The MSSI score has been proven to be representative in patients with 'classic' Fabry disease and may be useful for monitoring clinical improvement in patients receiving enzyme replacement therapy.

引用

页码：43 / 46

页数：4

共 5 条

[1]

Desnick RobertJ., 2001, The Metabolic and Molecular Bases of Inherited Disease, V8th, P3733, DOI DOI 10.1036/ommbid.181

[2] The use of scoring systems in patients with haematological malignancy [J].